This study by Nicolau et al
Back Deacon, DF, Johnsen, AH, Holst, JJ (March 1995) 'Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo', Journal Clinical Endocrinology Metabolism , 80/3, 952-7
Primary result at 12 mg: 24.2% mean weight loss
A recent study suggests a potential link between Ozempic (semaglutide) use and non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition that can cause sudden, permanent vision loss
Should this affect which plan I pick?" If a GLP-1 is part of your health picture, yes plan selection matters more than ever, because you need a Part D or Medicare Advantage plan to access the Bridge at all, and plans differ on the rest of your medications
What actually matters: Waist measurement